¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cross reactive antibody"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blue cross
    û½ÊÀÚ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross
    ±³Â÷
  • cross absorption
    ±³Â÷Èí¼ö
  • cross birth
    ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
  • cross fire irradiation
    ½ÊÀÚÆ÷È­Á¶»ç
  • cross fire technique
    ½ÊÀÚÆ÷È­Á¶»ç¹ý
  • cross fixation
    ±³Â÷ÁÖ½Ã
  • cross flap
    ±³Â÷ÇÇÆÇ
  • cross foot
    ¾ÈÂʹøÁü¹ß, ³»¹øÁ·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • blocking antibody
    Â÷´ÜÇ×ü
  • polyclonal antibody
    ´ÙŬ·ÐÇ×ü
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antibody synthesis
    Ç×üÇÕ¼º
  • antibody titer
    Ç×ü°¡
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • reactive nervous state
    ¹ÝÀÀ½Å°æ°ú¹Î»óÅÂ
  • cross absorption
    ±³Â÷Èí¼ö
  • cross-modal association
    ±³Â÷½Ä¿¬ÇÕ
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀÇ׿ø
  • blue cross
    û½ÊÀÚ
  • cross birth
    ³­»ê, ȾÀ§ºÐ¸¸
  • cross bridge
    ±³Â÷°áÇÕ, ¿¬°á´Ù¸®
  • cross
    ±³Â÷
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
  • cross-binding
    ±³Â÷¿¬°á
  • cross-contamination
    ±³Â÷¿À¿°
  • cross-eye
    (¢¡esotropia) ³»»ç½Ã
  • cross-face
    ±³Â÷¾ó±¼
  • cross-finger
    ±³Â÷Áö-, ¼Õ°¡¶ô±³Â÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reactive angioendotheliomatosis
    ¹ÝÀÀ¼º Ç÷°ü ³»ÇÇÁ¾Áõ
  • reactive arthritis
    ¹ÝÀÀ¼º°üÀý¿°
  • reactive attachment disorder
    ¹ÝÀÀ¼º ¾ÖÂø(äñó·)Àå¾Ö(º´)
  • reactive bone excrescence
    ¹ÝÀÀ¼º °ñ µ¹Ãâ
  • reactive depression
    ¹ÝÀÀ¼º ¿ì¿ïÁõ(ÚãëëàõéØê¦ñø).
  • reactive eosinophilia
    ¹ÝÀÀ¼º È£»ê±¸Áõ´ÙÁõ
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(¡­ÊÖòð).
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(ÚãëëàõÊÖòð)
  • reactive fibrosis
    ¹ÝÀÀ¼º ¼¶À¯È­
  • reactive functional hypoglycemia
    ¹ÝÀÀ¼º ±â´É¼º ÀúÇ÷´ç(¡­Ñ¦Òöàõî¸úìÓØ).
  • reactive hyperemia
    ¹ÝÀÀ¼º ÃæÇ÷(¡­õöúì)
  • reactive hypoglycemia
    ¹ÝÀÀ¼º ÀúÇ÷´çÁõ
  • reactive inflammation
    ¹ÝÀÀ¼º ¿°Áõ(Úãëëàõ)
  • reactive interface
    ¹ÝÀÀ¼º Á¢Ã˸é
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reactive attachment disorder
    ¹ÝÀÀ¼º ¾ÖÂø(äñó·)Àå¾Ö(º´)
  • reactive bone excrescence
    ¹ÝÀÀ¼º °ñ µ¹Ãâ
  • reactive depression
    ¹ÝÀÀ¼º ¿ì¿ïÁõ(ÚãëëàõéØê¦ñø).
  • reactive eosinophilia
    ¹ÝÀÀ¼º È£»ê±¸Áõ´ÙÁõ
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(¡­ÊÖòð).
  • reactive epilepsy
    ¹ÝÀÀ¼º °£Áú(ÚãëëàõÊÖòð)
  • reactive fibrosis
    ¹ÝÀÀ¼º ¼¶À¯È­
  • reactive functional hypoglycemia
    ¹ÝÀÀ¼º ±â´É¼º ÀúÇ÷´ç(¡­Ñ¦Òöàõî¸úìÓØ).
  • reactive hyperemia
    ¹ÝÀÀ¼º ÃæÇ÷(¡­õöúì)
  • reactive hypoglycemia
    ¹ÝÀÀ¼º ÀúÇ÷´çÁõ
  • reactive inflammation
    ¹ÝÀÀ¼º ¿°Áõ(Úãëëàõ)
  • reactive interface
    ¹ÝÀÀ¼º Á¢Ã˸é
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
  • reactive nervous state
    ¹ÝÀÀ¼º ½Å°æ°ú¹Î»óÅÂ(ÚãëëàõãêÌèΦÚÂßÒ÷¾).
  • reactive nodular hyperplasia
    ¹ÝÀÀ¼º °áÀýÁõ½Ä
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-infection
    ±³Â÷°¨¿°(Îßó©Êïæø)
  • cross-linker
    ±³Â÷¿¬°èÀÚ(Îßó©ææÍ¨í­)
  • cross-linking
    ±³Â÷¿¬°è(Îßó©ææÍ¨)
  • cross-matching
    ±³Â÷ÀûÇÕ°Ë»ç(Îßó©îêùêËþÞÛ)
  • cross-partition
    ±³Â÷ºÐ¹è(Îßó©ÝÂÛÕ)
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross-section
    Ⱦ´Ü¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AMA against medical advice; alkaline membrane assay; American Management Association; American Medical A...
NA Avogadro constant or number; nalidixic acid; Narcotics Anonymous; network administrator; neuraminida...
BRA bilateral renal agenesis; bone-resorbing activity; brain-reactive antibody
DRA dextran-reactive antibody
PRA panel-reactive antibody; phosphoribosylamine; physician recognition award; plasma renin activity; pr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PRA Panel Reactive Antibody
ARC American Red Cross
BCF Beat cross frequency
CP-MAS Cross Polarisation Magic Angle Spinning
CRD Cross Reacting Determinant
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross fire technique
    ½ÊÀÚÆ÷È­ Á¶»ç¹ý
  • cross heredity
    ±³Â÷ À¯Àü, ±³Â÷¼º À¯Àü
  • cross incision
    ½ÊÀÚ Àý°³
  • cross leg flap
    ÇÏÅð ±³Â÷ ÇÇÆÇ
  • cross linkage
    °¡±³È­
  • cross linking agent
    °¡±³Á¦
    ¼±»ó °íºÐÀÚÀÇ ºÐÀÚ°£À» È­ÇÐÀûÀ¸·Î °áÇÕÇϰí, ±×¹° ±¸Á¶¸¦ ¸¸µå´Â ÀÛ¿ëÀ» °®´Â ¹°Áú.
  • cross matching
    ±³Â÷ ½ÃÇè, ±³Â÷ ÀûÇÕ ½ÃÇè, ±³Â÷ ½ÃÇè¹ý, ±³Â÷ ÀûÇÕ ½ÃÇè¹ý
  • cross polymerization
    ±³Â÷ ÁßÇÕ
    ¼±»ó ÁßÇÕü ºÐÀÚ »çÀÌÀÇ È­ÇÐ °áÇÕ Çü¼ºÀº ±× ºÐÀÚµé·Î½á µÈ ¹«ÇÑ´ëÀÇ »ïÂ÷¿øÀû ¸Á»ó ±¸Á¶¿¡±îÁö À̸¦ ¼ö ÀÖ´Â ÁßÇÕ ¹ÝÀÀÀÌ´Ù. ±×·¡¼­ Àç·áÀÇ ¿ëÇØµµ, °­µµ, Èí¼ö¼ºÀ» ¹Ù²Ù´Â ÀÔüÀûÀÎ ¸Á»ó ±¸Á¶¸¦ Çü¼ºÇÏ°Ô µÈ´Ù.
  • cross reaction
    ±³Â÷ ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀÇ °¡Àå Å« Ư¡Àº ÀÌ ¹ÝÀÀÀÌ Æ¯ÀÌÀûÀ̶ó´Â °ÍÀε¥ ¶§·Î´Â ÀÌ ¿øÄ¢¿¡ ¸ÂÁö ¾Ê´Â ¹ÝÀÀÀ» º¸ÀÌ°Ô µÇ´Â ¼ö°¡ ÀÖ´Ù. ¿¹¸¦ µé¾î ¼ÒÀÇ Ç÷û ¾ËºÎ¹Î¿¡ ´ëÇÑ Ç×ü´Â ¾çÀÇ Ç÷û ¾ËºÎ¹Î°úµµ ¾î´À Á¤µµ ¹ÝÀÀÇϴµ¥ ÀÌ °°Àº ¹ÝÀÀÀ» ±³Â÷ ¹ÝÀÀÀ̶ó ÇÑ´Ù.
  • cross relaxation
    ±³Â÷ ÀÌ¿Ï
  • cross section radiography
    Ⱦ´Ü ¹æ»ç¼± ÃÔ¿µ¼ú
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross tolerance
    ±³Â÷ ³»¼º
  • cross-allergy
    ±³Â÷ ¾Ë·¹¸£±â
    ¸î¸î ±³Â÷ ¹ÝÀÀÇÏ´Â Ç׿ø¿¡ ´ëÇÑ ¾Ë·¹¸£±â¼º ¹ÝÀÀ. ÇÑ ¼ººÐ¿¡ ¾Ë·¯Áö ¹ÝÀÀÀÌ Àִ ȯÀÚ´Â ´Ù¸¥ À¯»çÇÑ ¼ººÐ¿¡µµ ¾Ë·¯Áö ¹ÝÀÀÀÌ ÀÖ´Â °æÇâÀÌ ÀÖ´Ù´Â »ç½Ç.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
C-reactive protein <protein> This blood test is used as an indicator of acute inflammation. C-reactive protein is a protein of the pentraxin family, produced by the liver during periods of inflammation and detectable in serum in various disease conditions particularly during the acute phase of immune response. Normally C-reactive protein should be negative in the bloodstream.
C-reactive protein is synthesised by hepatocytes and its production may be triggered by prostaglandin E1 or parogen. It consists of five polypeptide sub units forming a molecule of total molecular weight 105 kD. It binds to polysaccharides present in a wide range of bacterial, fungal and other cell walls or cell surfaces and to lecithin and to phosphoryl or choline containing molecules. It is related in structure to Serum Amyloid. And C polysaccharide.
Conditions which can cause a positive C-reactive protein include: rheumatoid arthritis, lupus, pneumococcal pneumonia, rheumatic fever, cancer, tuberculosis and myocardial infarction.
A positive C-reactive protein may also be seen in the later half of pregnancy and in some who are taking birth control pills.
See: acute phase proteins
(06 Oct 1997)
thiobarbituric acid reactive substances Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct.
(12 Dec 1998)
American Red Cross The national Red Cross society of the United States, established by Congress to assist in caring for the sick and wounded, serving as a communications link between members of the U.S. Armed forces and their families, conducting disaster relief and prevention programs, and furnishing other humanitarian services, the largest of which is a network of regional blood centres providing blood and blood products.
(05 Mar 2000)
anatomy, cross-sectional Descriptive anatomy based on three-dimensional imaging of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, magnetic resonance imaging, and computed tomography.
(12 Dec 1998)
back cross <genetics> A crossing of a heterozygous organism and one of its homozygous parents.
(09 Oct 1997)
blue cross A prepaid health insurance plan for hospital costs and related services. It usually excludes physicians' services (which are covered under blue shield).
(12 Dec 1998)
red cross An international agency providing various humanitarian services.
(12 Dec 1998)
collision cross-section <radiobiology> Effective surface area of a particle when it collides with another, describes probability of collisions between the two particles.
(09 Oct 1997)
cross 1. Any figure in the shape of a cross formed by two intersecting lines.
Synonym: crux.
Synonym: crux of heart.
3. A method of hybridization or the hybrid so produced.
Origin: F. Croix, L. Crux
(05 Mar 2000)
cross agglutination Agglutination by antibodies specific for minor (group) antigens common to several microorganisms, each of which possesses its own major specific antigen.
Synonym: cross agglutination.
(05 Mar 2000)
cross circulation The circulation in a portion of the body of one individual of blood supplied from another individual.
(12 Dec 1998)
cross contamination <dentistry> Passing bacteria or viruses indirectly from one patient to another through the use of improper sterilisation procedures, unclean instruments, or recycling of products.
(08 Jan 1998)
cross-cultural comparison Comparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies.
(12 Dec 1998)
cross-cultural psychiatry A field of psychiatry with interest in the study of psychological and psychiatric phenomena as differentially expressed in the cultures of different countries.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Geneva cross
    Àû½ÊÀÚ
  • George Cross
    Á¶Áö ÈÆÀå(George 4¼¼¶§ Á¦Á¤ 1943)
  • Greek cross
    ±×¸®½º ½ÊÀÚ°¡
  • Green Cross Code
    ±¹¹Î Çлý¿ë ±³Åë ¾ÈÀü ±ÔÄ¢
  • Holy Cross Day
    ¼º ½ÊÀÚ°¡ Âù¹ÌÀÇ ³¯(9¿ù 14ÀÏ)
  • International Committee of the Red Cross
    Àû½ÊÀÚ ±¹Á¦ À§¿øÈ¸(ICRC)
  • International Red Cross
    ±¹Á¦Àû½ÊÀÚ(»ç)(IRC)
  • Iron Cross
    (µ¶ÀÏÀÇ)ö½ÊÀÚ ÈÆÀå
  • Latin cross
    ¼¼·Î´ëÀÇ ¾Æ·¡ÂÊÀÌ ±ä º¸ÅëÀÇ ½ÊÀÚ°¡
  • Military Cross
    Àü°ø ½ÊÀÚ ÈÆÀå
  • Navy cross
    (¹Ì)ÇØ±º ¼öÈÆÀå;Ư°ø½ÊÀÚÈÆÀå
  • Northern Cross
    ºÏ½ÊÀÚ¼º(¹éÁ¶ÀÚ¸®)
  • Red Cross
    Àû½ÊÀÚ»ç;½ÊÀÚ±º(Ç¥Áö);(Èò ¹ÙÅÁ¿¡ ºÓÀº »öÀÇ)¼º Á¶Áö ½ÊÀÚÀå(À×±Û·£µåÀÇ ±¹Àå)
  • Roman cross
    ·Î¸¶ ½ÊÀÚ
  • Southern Cross,the
    ³²½ÊÀÚ¼º
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á